MATERIAL AND METHODS

Materials
as instructed by the manufacturer. Prehybridization and hybridization with radiolabeled oligonucleotides (36) at 50#{176}C and low stringency washes were as previously described (16, 32) . High stringency washes were in 6XSSC/0.1% SDS at the discriminatory temperature specified (see Fig. 3 ) for each ASO.
Cloning of PCR-amplified DNA
PCR-amplified DNA from exon 3 or exon 5 was purified on a 5% non- as directed by the manufacturer and blots were exposed to X-ray film for 10-45 s. exon 5 DNA using T7 DNA polymerase and the radiolabeled primer PCR-1, 5'-CCATGGATCAGGTACAAAGG (32). Exon 5 was amplified using primers E5, 5-ACTCCTTCCC-TTTATTAG, and PCR-2, described in Fig. 1 
Aldolase activity assays
Identification of new HF! mutations by SSCP analysis
The common HF! mutations, A149P, A174D, and N334K, were not found in PCR-amplified exons 5 and 9 from the patient (16), which indicated that the patient had two unidentified HFI mutations. SSCP analysis was applied to DNA from this patient for rapid identification of the exon (or exons) that encoded these unidentified HF! mutations. PCR-amplified protein-coding exons 2 through 9 from the patient were analyzed. Denatured DNA from exons 3 and 5 showed a different pattern of bands compared to that of wildtype exons 3 and 5 (Fig. 1) (Fig. 3) R''N R59op Figure  3 . Pedigree analysis of C134R and R59op mutations.
Exon 3 DNA was amplified using primers E3 and E3rc2 described in Fig. 2 ; exon 5 DNA was amplified using primers PCR-1 and PCR-2, described in Fig. 1 or R59op allele (exon 3 blots); lanes 3-12, amplified DNA from exon 5 or exon 3 from the patient's family members as indicated by the pedigree above.
The (Fig. 4) 
